Connect with us


Antibody to SARS-CoV-2 inhibits complement hyperactivation – News-Medical.Net

Although several monoclonal antibodies against the SARS-CoV-2 spike protein have been developed and clinically tested, little is known about antibodies to the nucleocapsid…



Article feature image

Researchers identified several antibodies to the nucleocapsid protein from a convalescent COVID-19 patient. Tests found some can inhibit complement hyperactivation and could potentially lead to new therapeutics.
Approximately half of all patients with severe COVID-19 disease develop acute respiratory distress, which can be fatal. Some patients also have symptoms similar to acute respiratory distress syndrome (ARDS). Studies have suggested that a hyperactive complement system, a part of the immune…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Toxic workplaces increase risk of depression by 300% – EurekAlert
Article feature image
Share your experience of having periods during menopause – The Guardian